2 employees
Alcinous Pharmaceuticals designs and develops new molecules that modulate the activity of well-established protein targets.
2016
$600K
from 1 investors over 1 rounds
Alcinous Pharmaceuticals raised $600K on May 12, 2020
Investors: Slater Technology Fund